• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Here's My 2018 Tax Loss Selling Recovery Portfolio Update

Overall performance is still better than both the S&P 500 and Russell 2000, but the gaps have narrowed considerably.
By JONATHAN HELLER
May 31, 2019 | 11:00 AM EDT
Stocks quotes in this article: KHC, WGO, UNFI, GIS, BBBY, KRO, GRPN, SKX, BCC, MEI, PETS

What a difference a month has made for my 2018 tax loss selling rebound tracking portfolio, as markets hit some turbulence. With both the S&P 500 (-5.1%) and Russell 2000 (-5.6%) down since my April update, this tracking portfolio of companies that suffered big losses in 2018, yet appeared to be somewhat attractively priced for potential rebound, gave back a lot of previous gains, and was down about 11%.

By way of reminder, qualifying companies had to meet the following criteria:

  • Down at least 30% year to date,
  • Forward price earnings ratios below 15 in the next two fiscal years
  • Minimum market cap $100 million

The resulting list was then whittled down from 200 to 12, and released in 3 tranches of 4 names each in mid-December. To date, 8 of the 12 names remain in positive territory, and are up an average of about 6%. Overall performance is still better than both the S&P 500 and Russell 2000, but the gaps have narrowed considerably.

Tranche 1, released on 12/10 remains in positive territory (+2%), still better than the Russell 2000 (+1.3%) but now lags the S&P 500 (+5.6%). Kraft Heinz (KHC) , down about 40%, remains the worst performer of the entire group, and investors continue to shun the name. Yesterday, Credit Suisse dropped its price target on KHC, which trades at less than 9.5 X next year's consensus estimates, and yields 5.8%, to $26. Winnebago (WGO) (+47%) remained the best performer of the entire portfolio, despite falling about 7% over the past month. United Natural Foods (UNFI) (-27%) is still not showing any signs of life. In fact, investors are so sour on the name that it trades at about 5.5 X next year's consensus estimates. General Mills (GIS) (+30%) is the second best overall performer.

Tranche 2, released on 12/12 is up 10% on average, better than the S&P 500 (+5.5%) and Russell 2000 (+3.7%). Bed Bath & Beyond (BBBY) (+5%) had an awful month falling 24%, and giving back most of its gains, as retailers struggled overall and it struggled with some internal issues. Kronos Worldwide (KRO) (+13%) fell about 9% over the month, and now trades at 8.5 X next year's consensus estimates. Groupon (GRPN) (+14%) fell slightly for the month, but has very quietly outperformed.

Tranche 3, released on 12/14 is up an average of 5.9%, just ahead the S&P 500 (5%) and Russell 2000 (+2.8%). Skechers (SKX) (+19%) fell 10% for the month as tariff worries weighed on the apparel sector. Boise Cascade (BCC) (-3%) fell 17% giving back all of its gains and more as the company missed first quarter earnings estimates. Methode Electronics (MEI) (+14%) fell 10% over the month on no news. PetMed Express (PETS) (-19%) fell about 20%, primarily due to a fourth quarter earnings miss. PETS trades at 10 X next year's consensus earnings estimates, and yields 6%. I think of this company from time to time while giving our beloved dog twice/day insulin shots, something I could not imagine ever doing.

As I mentioned earlier this week, lower quality and more distressed names are getting beat up pretty badly these days; they are typically the first to be sold when markets become rocky. Overall, that explains the rather rough month for this tracking portfolio.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Jonathan Heller had no position in the securities mentioned.

TAGS: Investing | Markets | Stocks | Trading

More from Investing

The Markets Also Rise Quickly

James "Rev Shark" DePorre
Mar 1, 2021 4:22 PM EST

Fear of missing out permeated the day as the indexes bounced back.

NantKwest's Charts Are Extended When Compared to the Popular Moving Averages

Bruce Kamich
Mar 1, 2021 3:15 PM EST

Let's stand aside for now and see how things unfold.

Wendy's Charts Just Made Me Lose My Appetite for Investing

Bruce Kamich
Mar 1, 2021 2:21 PM EST

Here's why diving in now might lead to heartburn....

The Battle Over Cannabis Operator Verano Holdings' Stock

Debra Borchardt
Mar 1, 2021 2:00 PM EST

Sol Global and MMCap are fighting in court over who owns or owes what of the company's shares.

Is Chevron Finally Ready to Make an Upside Breakout?

Bruce Kamich
Mar 1, 2021 1:44 PM EST

Let's check out some charts on the energy giant.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 06:05 PM EST PAUL PRICE

    Michael's (MIK) up on take-over rumors

    The NYT says talks are underway regarding a buyo...
  • 08:09 AM EST GARY BERMAN

    Monday Morning Fibocall for 3/1/2021

    Always a good idea to know where our bounce zones ...
  • 11:51 AM EST REAL MONEY

    Watch Bob Lang and Doug Kass Discuss Short-Selling!

    Bob Lang and Doug Kass with an engaging and educat...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login